Alfarecin (interferon) lyophilisate for solution for injections 3 mln IU vial №10

$299.00

Manufacturer: Ukraine

Purpose: Alfarecin (interferon) stimulates immune response to treat viral infections.

SKU: MED56298 Category:

Description

Alfarecin (Interferon) Lyophilisate for Solution for Injections 3 mln IU Vial №10

Ingredients

Each vial contains:

  • Interferon alpha-2b (recombinant) – 3 million IU
  • Lactose monohydrate
  • Glutamic acid
  • Mannitol

Dosage

Dosage and administration: The recommended dose of Alfarecin is determined by the prescribing healthcare provider based on the patient’s condition. It is administered via subcutaneous or intramuscular injection.

Indications

Alfarecin is indicated for:

  • Chronic hepatitis B and C
  • Kaposi’s sarcoma
  • Genital warts
  • Chronic myeloid leukemia

Contraindications

Do not use Alfarecin if:

  • You are allergic to interferon alpha-2b or any other ingredients in the product
  • You have autoimmune hepatitis
  • You are pregnant or breastfeeding

Directions

Before administration: Reconstitute the lyophilisate with the provided diluent according to the instructions. Administer the solution immediately after reconstitution.

Scientific Evidence

Alfarecin’s efficacy: Studies have shown that interferon alpha-2b has antiviral, antiproliferative, and immunomodulatory effects, making it effective in the treatment of various viral infections and cancers. Research has demonstrated its ability to inhibit viral replication and promote immune response against infected cells.

Additional Information

Storage: Store Alfarecin lyophilisate at controlled room temperature. Protect from light and moisture. Do not freeze.

Interferons are a group of signaling proteins produced by the body in response to pathogens. Interferon alpha-2b, the active ingredient in Alfarecin, works by binding to specific receptors on cells, triggering a cascade of immune responses that help the body fight infections and regulate cell growth.

Clinical trials have shown that Alfarecin is well-tolerated and effective in improving outcomes in patients with chronic viral hepatitis and certain types of cancer. Its use in combination therapy has been particularly promising in enhancing treatment response rates and reducing disease progression.